These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 23701927)

  • 21. [Visualization of intimal proliferation of drug-eluting stent and bare mental stent by use of optical coherence tomography].
    Chen BX; Ma FY; Luo W; Xie WL; Sun SH; Guo XM; Wang F; Zhao XZ; Chu XW
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(16):1102-6. PubMed ID: 16796834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: optical coherence tomography substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial.
    Guagliumi G; Costa MA; Sirbu V; Musumeci G; Bezerra HG; Suzuki N; Matiashvili A; Lortkipanidze N; Mihalcsik L; Trivisonno A; Valsecchi O; Mintz GS; Dressler O; Parise H; Maehara A; Cristea E; Lansky AJ; Mehran R; Stone GW
    Circulation; 2011 Jan; 123(3):274-81. PubMed ID: 21220730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioresorbable vascular scaffold strut disruption after crossing with an optical coherence tomography imaging catheter.
    Sato K; Panoulas VF; Naganuma T; Miyazaki T; Latib A; Colombo A
    Int J Cardiol; 2014 Jul; 174(3):e116-9. PubMed ID: 24814543
    [No Abstract]   [Full Text] [Related]  

  • 24. Bioresorbable Vascular Scaffold Thrombosis: Clinical and Optical Coherence Tomography Findings.
    Cuesta J; García-Guimaraes M; Basante T; Rivero F; Antuña P; Alfonso F
    Rev Esp Cardiol (Engl Ed); 2019 Jan; 72(1):90-91. PubMed ID: 29223378
    [No Abstract]   [Full Text] [Related]  

  • 25. Serial assessment of coronary artery response to paclitaxel-eluting stents using optical coherence tomography.
    Guagliumi G; Bezerra HG; Sirbu V; Ikejima H; Musumeci G; Biondi-Zoccai G; Lortkipanidze N; Fiocca L; Capodanno D; Wang W; Tahara S; Vassileva A; Matiashvili A; Valsecchi O; Costa MA
    Circ Cardiovasc Interv; 2012 Feb; 5(1):30-8. PubMed ID: 22298797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of neointimal coverage and thrombosis at 3 months and 2 years post sirolimus-eluting stent implantation by optical coherence tomography].
    Xie Y; He SH; Gu X; Xu RX; Masamichi T; Kyoichi M
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Feb; 38(2):116-20. PubMed ID: 20398555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serial optical coherence tomography-based observation of strut coverage on drug-eluting stent crossing side-branch vessels.
    Lee SY; Kim JS; Shin DH; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    J Invasive Cardiol; 2012 Nov; 24(11):569-73. PubMed ID: 23117310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Geometrically correct three-dimensional optical coherence tomography: first self-expanding bifurcation stent evaluation.
    Antoniadis AP; Jaguszewski M; Maier W; Giannoglou GD; Lüscher TF; Templin C
    Eur Heart J; 2013 Sep; 34(34):2715. PubMed ID: 23832492
    [No Abstract]   [Full Text] [Related]  

  • 29. Five-year optical coherence tomography follow-up of an everolimus-eluting bioresorbable vascular scaffold: changing the paradigm of coronary stenting?
    Karanasos A; Simsek C; Serruys P; Ligthart J; Witberg K; van Geuns RJ; Sianos G; Zijlstra F; Regar E
    Circulation; 2012 Aug; 126(7):e89-91. PubMed ID: 22891170
    [No Abstract]   [Full Text] [Related]  

  • 30. [Role of bioresorbable scaffold and optical coherence tomography in the treatment of recurrent in-stent restenosis: a case report].
    Mattesini A; Dall'Ara G; Rama-Merchan JC; Ghione M; Foin N; Secco GG; Di Mario C
    G Ital Cardiol (Rome); 2013 Dec; 14(12):836-8. PubMed ID: 24336600
    [No Abstract]   [Full Text] [Related]  

  • 31. The effects of drug-eluting stent polymer on measurement of strut thickness by optical coherence tomography: in-vitro comparison with bare-metal stent.
    Mizuno M; Takano M; Mizuno K
    Int J Cardiol; 2010 Nov; 145(1):48-9. PubMed ID: 19398139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo evaluation of stent strut distribution patterns in the bioabsorbable everolimus-eluting device: an OCT ad hoc analysis of the revision 1.0 and revision 1.1 stent design in the ABSORB clinical trial.
    Okamura T; Garg S; Gutiérrez-Chico JL; Shin ES; Onuma Y; García-García HM; Rapoza RJ; Sudhir K; Regar E; Serruys PW
    EuroIntervention; 2010 Apr; 5(8):932-8. PubMed ID: 20542778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of neointimal coverage of overlapping sirolimus-eluting stents by optical coherence tomography.
    Tian F; Chen YD; Sun ZJ; Chen L; Yuan F; Song XT; Lü SZ
    Chin Med J (Engl); 2009 Mar; 122(6):670-4. PubMed ID: 19323932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intracoronary thrombus formation after drug-eluting stents implantation: optical coherence tomographic study.
    Kim JS; Hong MK; Fan C; Kim TH; Shim JM; Park SM; Ko YG; Choi D; Jang Y
    Am Heart J; 2010 Feb; 159(2):278-83. PubMed ID: 20152227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tissue characterization after drug-eluting stent implantation using optical coherence tomography.
    Malle C; Tada T; Steigerwald K; Ughi GJ; Schuster T; Nakano M; Massberg S; Jehle J; Guagliumi G; Kastrati A; Virmani R; Byrne RA; Joner M
    Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1376-83. PubMed ID: 23539216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Local aneurysmal dilatation mimicking stent malapposition and concurrent vulnerable plaque within neointima of normal lumen after drug-eluting stent implantation: primary new findings from optical coherence tomography.
    Guo YL; Yang YJ; Gao Z; Qian J
    Chin Med J (Engl); 2012 Mar; 125(6):1186-8. PubMed ID: 22613553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Morphologic characteristics of late stent malapposition after drug-eluting stents implantation by optical coherence tomography follow-up.
    Hou JB; Liu HM; Ma LJ; Yang S; Meng LB; Han ZG; Zhang S; Yu B
    Chin Med J (Engl); 2010 Mar; 123(5):581-4. PubMed ID: 20367985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Evaluation of the late stent malposition after drug-eluting stent implantation by optical coherence tomography].
    Tian F; Chen YD; Sun ZJ; Chen L; Liu HB; Yang TS; Liu CF; Jin QH; Bai QC
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Jul; 37(7):585-9. PubMed ID: 19961724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tissue coverage and neointimal hyperplasia in overlap versus nonoverlap segments of drug-eluting stents 9 to 13 months after implantation: in vivo assessment with optical coherence tomography.
    Gutiérrez-Chico JL; Räber L; Regar E; Okamura T; di Mario C; van Es GA; Windecker S; Serruys PW
    Am Heart J; 2013 Jul; 166(1):83-94. PubMed ID: 23816026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histopathologic validation of optical coherence tomography findings of non-apposed side-branch struts in porcine arteries.
    Her AY; Kim JS; Kim YH; Shin DH; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    J Invasive Cardiol; 2013 Jul; 25(7):364-6. PubMed ID: 23813068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.